 |
|
|
| |
A Quantitative Model of ART Efficacy Explains the
Clinical Success of Dolutegravir
|
| |
| |
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Sarah B. Laskey1 & Robert F. Siliciano1,2
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
2Howard Hughes Medical Institute, Baltimore, Maryland, USA
|
| |
|
|
|
|
|
